Centre plans to roll out SII qHPV vaccine for girls aged 9-14 years under National Immunization Programme Ruchika Sharma11 Aug 2022 4:30 PM ISTCervical cancer can be prevented by vaccinating girls in the age group of 9-14 years with HPV vaccine, the sources said.
Serum Institute to supply 1 crore qHPV vaccine doses by December: Sources Ruchika Sharma2 Aug 2022 11:34 AM ISTCervical cancer in India ranks as the second most frequent cancer among women aged between 15 and 44 years.
SII to launch QHPV vaccine against cervical cancer Rahul Verma14 July 2022 10:42 AM ISTIndia's first Quadrivalent Human Papillomavirus vaccine (qHPV) against cervical cancer gets Drugs Controller General of India's (DCGI) approval for...
FIRST: Serum Institute gets DCGI nod for qHPV vaccine against cervical cancer Ruchika Sharma13 July 2022 11:37 AM ISTThe National Technical Advisory Group on Immunisation (NTAGI) had recently also approved the qHPV after reviewing the clinical trial data of the...
Maha: Dr Mohan R Wani appointed as Director of National Centre for Cell Science Sanchari Chattopadhyay8 July 2022 10:45 AM ISTPune: Renowned scientist, Dr Mohan R Wani has taken charge as the new director of the Pune-based National Centre for Cell Science (NCCS). Last year he...
COVID-19: DCGI nod to Gennova's indigenous mRNA vaccine for emergency use in 18 years and above; SII's Covovax for 7-11 years Ruchika Sharma29 Jun 2022 10:00 AM ISTGennova developed the mRNA vaccine with the support of the Department of Biotechnology (DBT) under the Ministry of Science and Technology and its PSU,...
Govt advisory panel to review trial data on Serum Institute qHPV vaccine against cervical cancer Ruchika Sharma27 Jun 2022 11:29 AM ISTNew Delhi: The government advisory panel NTAGI is likely to review on June 28 trial data on India's first quadrivalent human papillomavirus (qHPV)...
CDSCO panel recommends market nod for Serum Institute qHPV vaccine against cervical cancer Ruchika Sharma16 Jun 2022 1:45 PM ISTIn the application, Singh is learnt to have stated that qHPV vaccine CERVAVAC has demonstrated robust antibody response that is nearly 1,000 times...
SEC to review Serum Institute qHPV vaccine trial data today Ruchika Sharma15 Jun 2022 11:20 AM ISTNew Delhi: The first indigenously developed quadrivalent human papillomavirus (qHPV) vaccine against cervical cancer by the Serum Institute of India...
Serum Institute seeks DCGI nod to manufacture qHPV vaccine Cervavac against cervical cancer Ruchika Sharma9 Jun 2022 12:39 PM IST"This will fulfill the dream of our hon'ble Prime Minister Narendra Modi 'VOCAL FOR LOCAL' and 'MAKING IN INDIA FOR THE WORLD' and will ensure...
Govt grants Rs 24 crore to Epygen Biotech to begin cost-effective COVID vaccine trials Ruchika Sharma13 April 2022 3:39 PM ISTThe vaccine will be made available to the government as well as for private consumption and is expected to hit the Indian market by the end of 2022 or...
Telangana Govt developing Biopharma Hub at Genome Valley MD Bureau7 Sept 2021 9:00 AM ISTHyderabad: To give impetus to biopharmaceutical research and manufacturing, the Telangana government on Sunday announced that it is developing...
